CureVac N.V. (NASDAQ:CVAC) on Thursday said the European Patent Office (EPO) confirmed the validity of CureVac’s European patent EP 3 708 668 B1 subject to amendments to specify the scope of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback